The 2nd International Congress on Clinical Trials on Cannabis, London
Advancing the application of cannabinoid therapy in many areas of clinical medicine.
CT-Cann2022 will again bring together leading researchers, clinicians, industry professionals and other related experts from around the globe to discuss ways of improving current research strategies, new discoveries, practical dilemmas and future avenues in this rapidly evolving field.
We will touch, among other things, on basic and clinical methodologies, new findings, regulatory and legal issues, pharmacological considerations, and technological advancements. We will emphasize practical implications for patients, researchers, prescribing clinicians and industry leaders.
CT-Cann2022 will thus inform participants of the latest evidence and concepts regarding cannabinoid therapy, aid prescribers to practically implement best practices based on the clinical implications of current research and expert opinions, serve as a platform for an exchange of ideas and practices in cannabinoid medicine, and bring together clinicians, patients and industry leaders in innovative and engaging discussions. As before, it will undoubtedly spark many fascinating and lively debates.
We look forward to welcoming you at CT-Cann2022 in the once again vibrant and wonderful city of London.